Brainstorm Cell Therapeu... Stock Price

-0.22 (-4.25%)
Upgrade to Real-Time
Afterhours (Closed)
Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
Small Cap Basic
Monthly Subscription
for only
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Brainstorm Cell Therapeutics Inc BCLI NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.22 -4.25% 4.96 19:54:50
Open Price Low Price High Price Close Price Previous Close
5.16 4.85 5.44 4.99 5.18
Bid Price Ask Price Spread News
4.96 5.00 0.04 - -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
8,254 2,094,419 $ 5.09 $ 10,657,818 1,908,707 3.63 - 17.95
Last Trade Time Type Quantity Stock Price Currency
19:54:50 formt 100 $ 4.96 USD

Brainstorm Cell Therapeu... Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 156.58M 31.57M 26.70M $ - $ - -1.06 -4.60
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% 35.00k 7.40%

more financials information »

Brainstorm Cell Therapeu... News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical BCLI Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week4.105.443.814.463,266,1570.8620.98%
1 Month10.3412.813.805.632,010,368-5.38-52.03%
3 Months12.2017.953.808.551,128,219-7.24-59.34%
6 Months6.7517.953.8010.00891,482-1.79-26.52%
1 Year3.9517.953.638.50698,8061.0125.57%
3 Years3.9517.952.887.64292,1821.0125.57%
5 Years2.6317.951.906.64228,2762.3388.59%

Brainstorm Cell Therapeu... Description

Brainstorm Cell Therapeutics Inc is a biotechnology company. The company is developing novel adult stem cell therapies for debilitating neurodegenerative disorders such as Amyotrophic Lateral Sclerosis (ALS, also known as Lou Gehrig's disease), Progressive Multiple Sclerosis (PMS), and Parkinson's disease (PD). Brainstorm's NurOwn, its proprietary process for the propagation of Mesenchymal Stem Cells (MSC) and differentiation into neurotrophic factor-(NTF) secreting cells (MSC-NTF), and their transplantation at, or near, the site of damage, offers the hope of more effectively treating neurodegenerative diseases.

Your Recent History
Gulf Keyst..
FTSE 100
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.